ScholarIQanswers from OpenAlex & ORCID
C. David James
ResearcherPublications, citations & collaboration network
C. David James is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does C. David James have?
ScholarIQindexed works
C. David James has 389 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does C. David James have?
ScholarIQcitation count
C. David James has 38,883 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of C. David James?
ScholarIQh-index
C. David James has an h-index of 103 in OpenAlex.
What is the i10-index of C. David James?
ScholarIQi10-index
C. David James has an i10-index of 234 in OpenAlex.
What is the ORCID of C. David James?
ScholarIQorcid
The ORCID for C. David James is on the source record.
What is the OpenAlex record for C. David James?
ScholarIQopenalex
The OpenAlex for C. David James is on the source record.
What are the most-cited papers on C. David James?
ScholarIQmost cited works
Evidence for Sequenced Molecular Evolution of <i>IDH1</i> Mutant Glioblastoma From a Distinct Cell of Origin
Albert Lai, Samir Kharbanda, Whitney B. Pope, Anh Tran, Orestes E. Solis, Franklin Peale, William F. Forrest, Kanan Pujara, Jose Carrillo, Ajay Pandita, Benjamin M. Ellingson, Chauncey W. Bowers, Robert Soriano, Nils Ole Schmidt, Sankar Mohan, William H. Yong, Somasekar Seshagiri, Zora Modrušan, Zhaoshi Jiang, Kenneth Aldape, Paul S. Mischel, Linda M. Liau, Cameron Escovedo, Weidong Chen, Phioanh L. Nghiemphu, C. David James, Michael D. Prados, Manfred Westphal, Katrin Lamszus, Timothy F. Cloughesy, Heidi Phillips
Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Michael D. Prados, Susan M. Chang, Nicholas Butowski, Rebecca DeBoer, Rupa Parvataneni, Hannah Carliner, Paul Kabuubi, Jennifer Ayers-Ringler, Jane Rabbitt, Margaretta Page, Anne Fedoroff, Penny K. Sneed, Mitchel S. Berger, Michael W. McDermott, Andrew T. Parsa, Scott R. VandenBerg, C. David James, Kathleen R. Lamborn, David Stokoe, Daphne A. Haas‐Kogan
A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma
Priya Kumthekar, Caroline H. Ko, Tatjana Paunesku, Karan Dixit, Adam M. Sonabend, Orin Bloch, Matthew C. Tate, Margaret Schwartz, Laura Zuckerman, Ray Lezon, Rimas V. Lukas, Borko Jovanovic, Kathleen McCortney, Howard Colman, Si Chen, Barry Lai, Olga Antipova, Junjing Deng, Luxi Li, Serena Tommasini-Ghelfi, Lisa Hurley, Dusten Unruh, Nitya V. Sharma, Manoj Kandpal, Fotini M. Kouri, Ramana V. Davuluri, Daniel J. Brat, Miguel Muzzio, Mitchell Glass, Vinod Vijayakumar, Jeremy D. Heidel, Francis J. Giles, Ann K. Adams, C. David James, Gayle E. Woloschak, Craig Horbinski, Alexander H. Stegh
Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth
Jonathan B. Lamano, Jason Balquidera Lamano, Yuping D. Li, Joseph D. DiDomenico, Winward Choy, Dorina Veliceasa, Daniel E. Oyon, Shayan Fakurnejad, Leonel Ampie, Kartik Kesavabhotla, Rajwant Kaur, Gurvinder Kaur, Dauren Biyashev, Dusten Unruh, Craig Horbinski, C. David James, Andrew T. Parsa, Orin Bloch